Aug 10 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2023 Jun 30, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 6 mln 9 mln 127 mln
(-26.6 pct) (+26.7 pct) (+214.9 pct)
Operating loss 478 mln loss 374 mln loss 830 mln
Recurring loss 480 mln loss 382 mln loss 783 mln
Net loss 481 mln loss 381 mln loss 786 mln
EPS loss 14.97 yen loss 15.50 yen loss 22.34 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T